Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Glycine"
topic_facet:"Research Support, Non-U.S. Gov't"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Glycine%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22Gupta%2C+Neeraj%22&type=Person
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Glycine%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22Gupta%2C+Neeraj%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Glycine%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22Gupta%2C+Neeraj%22&type=Person
PubPharm (23)
1
Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE-MM1 study in multiple myeloma patients
enthalten in:
CPT: pharmacometrics & systems pharmacology
| 2022
von
Srimani, J.
|
Diderichsen, P.
|
Hanley, M.
| +3
Wird geladen...
2
Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma
enthalten in:
British journal of haematology
| 2019
von
Kumar, S.
|
Grzasko, N.
|
Delimpasi, S.
| +9
Wird geladen...
3
Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor
enthalten in:
Clinical pharmacology and therapeutics
| 2019
von
Gupta, N.
|
Hanley, M.
|
Diderichsen, P.
| +9
Wird geladen...
4
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
enthalten in:
European journal of cancer (Oxford, England : 1990)
| 2019
von
Dimopoulos, M.
|
Grosicki, S.
|
Jędrzejczak, W.
| +10
Wird geladen...
5
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3) : a double-blind, randomised, placebo-controlled phase 3 trial
enthalten in:
Lancet (London, England)
| 2019
von
Dimopoulos, M.
|
Gay, F.
|
Schjesvold, F.
| +124
CommentIn: Lancet. 2019 Jan 19;393(10168):204-205. - PMID 30545778
Wird geladen...
6
Biotransformation of [14C]-ixazomib in patients with advanced solid tumors : characterization of metabolite profiles in plasma, urine, and feces
enthalten in:
Cancer chemotherapy and pharmacology
| 2018
von
Pusalkar, S.
|
Plesescu, M.
|
Gupta, N.
| +6
Wird geladen...
7
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
enthalten in:
Haematologica
| 2018
von
San-Miguel, J.
|
Echeveste Gutierrez, M.
|
Špicka, I.
| +13
Wird geladen...
8
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma
enthalten in:
British journal of haematology
| 2018
von
Richardson, P.
|
Hofmeister, C.
|
Rosenbaum, C.
| +15
Wird geladen...
9
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors
enthalten in:
Investigational new drugs
| 2018
von
Gupta, N.
|
Zhang, S.
|
Pusalkar, S.
| +8
Wird geladen...
10
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor : Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis
enthalten in:
Journal of clinical pharmacology
| 2018
von
Gupta, N.
|
Hanley, M.
|
Venkatakrishnan, K.
| +13
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Glycine
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Medienart
23
Aufsätze
23
E-Artikel
23
E-Ressourcen
Zeitschriftentitel
3
Blood
3
Investigational new drugs
2
British journal of clinical pharmacology
2
British journal of haematology
2
Cancer chemotherapy and pharmacology
2
Journal of clinical pharmacology
1
CPT: pharmacometrics & systems pharmacology
1
Clinical pharmacokinetics
1
Clinical pharmacology and therapeutics
1
European journal of cancer (Oxford, England : 1...
1
Haematologica
1
Journal of hematology & oncology
1
Lancet (London, England)
1
Targeted oncology
1
The Lancet. Oncology
Alle anzeigen ...
weniger ...
Thema
23
71050168A2
23
Boron Compounds
Glycine
23
Journal Article
Research Support, Non-U.S. Gov't
23
TE7660XO1C
23
ixazomib
15
Clinical Trial, Phase I
13
Proteasome Inhibitors
8
Multicenter Study
7
Antineoplastic Agents
7
Clinical Trial, Phase II
5
7S5I7G3JQL
5
Dexamethasone
5
Randomized Controlled Trial
3
F0P408N6V4
3
Ixazomib
3
Lenalidomide
3
multiple myeloma
3
proteasome inhibitor
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2020-
22
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
23
Englisch
Haven't found what you're looking for?
Wird geladen...